Clinical Trial: A Single-Arm Clinical Study of Concurrent Chemoradiotherapy with Cetuximab and Induction Therapy with TP Chemotherapy Combined with Tislelizumab for HPV-Negative, Stage IVA-IVB Head and Neck Squamous Cell Carcinoma (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Arm Clinical Study of Concurrent Chemoradiotherapy with Cetuximab and Induction Therapy with TP Chemotherapy Combined with Tislelizumab for HPV-Negative, Stage IVA-IVB Head and Neck Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132973

Registration Time: 2026/09/20

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Army Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344441

Published by HT Digital Content Services with permission from Health Daily Digest....